The transcriptional activity of the Cox-2 and VEGF promoters was evaluated in cervical cancer cell lines with and without anti-inflammatory reagents sodium salicylate, dexamethasone, salicylic acid and TGF-β1 (Fig. 2a–h). This evidence concerns the gene VEGFA and cervical carcinoma.